Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

LH Lindner; S Litiere; Stefan Sleijfer; C Benson; A Italiano; B Kasper; C Messiou; H Gelderblom; E Wardelmann; A le Cesne; JY Blay; S Marreaud; N Hindi; IME Desar; A Gronchi; WTA van der Graaf

doi:10.1002/ijc.31286

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

LH Lindner, S Litiere, Stefan Sleijfer, C Benson, A Italiano, B Kasper, C Messiou, H Gelderblom, E Wardelmann, A le Cesne, JY Blay, S Marreaud, N Hindi, IME Desar, A Gronchi, WTA van der Graaf

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2610-2620
Number of pages	11
Journal	International Journal of Cancer
Volume	142
Issue number	12
DOIs	https://doi.org/10.1002/ijc.31286
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.31286

RePub-111207-OA.pdfFinal published version, 633 KB

http://hdl.handle.net/1765/111207

Cite this

Lindner, LH., Litiere, S., Sleijfer, S., Benson, C., Italiano, A., Kasper, B., Messiou, C., Gelderblom, H., Wardelmann, E., le Cesne, A., Blay, JY., Marreaud, S., Hindi, N., Desar, IME., Gronchi, A., & van der Graaf, WTA. (2018). Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). International Journal of Cancer, 142(12), 2610-2620. https://doi.org/10.1002/ijc.31286

Lindner, LH ; Litiere, S ; Sleijfer, Stefan et al. / Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). In: International Journal of Cancer. 2018 ; Vol. 142, No. 12. pp. 2610-2620.

@article{1dcbf5e349e3486aa195113e114e61ee,

title = "Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)",

author = "LH Lindner and S Litiere and Stefan Sleijfer and C Benson and A Italiano and B Kasper and C Messiou and H Gelderblom and E Wardelmann and {le Cesne}, A and JY Blay and S Marreaud and N Hindi and IME Desar and A Gronchi and {van der Graaf}, WTA",

year = "2018",

doi = "10.1002/ijc.31286",

language = "Undefined/Unknown",

volume = "142",

pages = "2610--2620",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "12",

}

Lindner, LH, Litiere, S, Sleijfer, S, Benson, C, Italiano, A, Kasper, B, Messiou, C, Gelderblom, H, Wardelmann, E, le Cesne, A, Blay, JY, Marreaud, S, Hindi, N, Desar, IME, Gronchi, A & van der Graaf, WTA 2018, 'Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)', International Journal of Cancer, vol. 142, no. 12, pp. 2610-2620. https://doi.org/10.1002/ijc.31286

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). / Lindner, LH; Litiere, S; Sleijfer, Stefan et al.
In: International Journal of Cancer, Vol. 142, No. 12, 2018, p. 2610-2620.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

AU - Lindner, LH

AU - Litiere, S

AU - Sleijfer, Stefan

AU - Benson, C

AU - Italiano, A

AU - Kasper, B

AU - Messiou, C

AU - Gelderblom, H

AU - Wardelmann, E

AU - le Cesne, A

AU - Blay, JY

AU - Marreaud, S

AU - Hindi, N

AU - Desar, IME

AU - Gronchi, A

AU - van der Graaf, WTA

PY - 2018

Y1 - 2018

U2 - 10.1002/ijc.31286

DO - 10.1002/ijc.31286

M3 - Article

SN - 0020-7136

VL - 142

SP - 2610

EP - 2620

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 12

ER -

Lindner LH, Litiere S, Sleijfer S, Benson C, Italiano A, Kasper B et al. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). International Journal of Cancer. 2018;142(12):2610-2620. doi: 10.1002/ijc.31286